Latest Updates
July 2008 Combination Trial Updates and Additions

Protocol ID	Trial Title
UCCRC-11956A; NCI-5701; UCCRC-NCI-5701; NCT00055913	Bevacizumab and Erlotinib in Treating Patients with Recurrent or Metastatic Head and Neck Cancer
CC-5013-MM-011; NCT00091624	A Phase I Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)
EGF104900; NCT00320385	A Multicenter, Randomized, Open Label, Phase III Clinical Trial of Lapatinib in Combination With Trastuzumab Versus Lapatinib Monotherapy in Patients With Metastatic Breast Cancer That Progressed on Trastuzumab-Containing Regimens
07-202; NCT00556205	Phase II, Randomized Trial of Continuous Dosing Sunitinib and/or Bevacizumab in Sunitinib-Refractory Patients With Metastatic Renal Cell Carcinoma
06-016; NCT00421512	A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients